National Institute on Minority Health and Health Disparities (NIMHD)

Mission Statement

The NIMHD Mission is to support the advancement of scientific knowledge and improving the health of NIH-designated populations experiencing health disparities.


Interest Areas

General Topics

NIMHD scientific interests emphasize major diseases, conditions, and health-related behaviors that account for a large share of morbidity and mortality and for which substantial differences in risk, disease progression, treatment response, and outcomes are well documented. Priority areas focus on clinically actionable conditions; biologic, behavioral, and environmental mechanisms; early detection and prevention; treatment optimization; and implementation strategies that can improve measurable health outcomes. 

General topics of interest include but are not limited to:

  • Cardiometabolic disease
  • Cardiovascular disease and stroke
  • Maternal health and pregnancy-related complications 
  • Cancer prevention, early detection, treatment outcomes, and survivorship 
  • Chronic kidney disease
  • Asthma and chronic respiratory disease
  • Dementia and vascular cognitive impairment
  • HIV/AIDS
  • Sickle cell disease and other high-burden genetic/hematologic conditions
  • Mental illness and suicide prevention
  • Tobacco use, substance use, and overdose
  • Physical activity, sedentary behavior, and functional decline 
  • Nutrition-related behaviors and food-linked chronic disease risk 
  • Multimorbidity and high-need/high-cost patients

Cross-cutting scientific approaches include:

  • Community engaged research
  • Early detection, risk stratification, and predictive analytics
  • Mechanistic and translational science 
  • Adherence and treatment optimization
  • Behavioral science
  • Digital health and remote care
  • Environmental and exposure science when linked to disease outcomes
  • Clinical trials and pragmatic clinical trials
  • Data science and real-world data
  • Interdisciplinary team science
  • Implementation science tied to clinical endpoints

Highlighted Topics

Highlighted Topics identify timely or emerging research priorities across one or more NIH Institutes, Centers, or Offices (ICOs). Use Parent Announcements or other broad NIH opportunities to submit investigator-initiated applications on a topic. While Highlighted Topics do not affect referral or review, some include dedicated funding. See the Highlighted Topic FAQs for details.

Title Lead ICO Participating ICOs Posted Date Expiration Date

Funding Opportunities and Notices

Search for NIMHD’s funding opportunities and notices


ICO Funding Policies and Considerations

Visit NIH Fiscal Policies for NIH-wide information on appropriations and other budgetary information (salary limits, stipends, tuition/fees) and Funding Decisions to learn about NIH's consistent and unified approach for making funding decisions.

NIMHD Funding Policies and Considerations builds on that general information.


Additional Information by Funding Category

Administrative Supplements
In addition to our Administrative Supplements overview, consider the following NIMHD-specific information.
Administrative Supplement Contact:

Reach out to the grants management and program officials named on the parent grant Notice of Award to discuss possible funding options available.

Individual Career Development
In addition to our Individual Career Development, consider the following NIMHD-specific information.
Individual Career Development Interest Areas:

NIMHD supports novel mechanistic and observational studies with a multidisciplinary team seeking to improve minority health and reduce health care disparities through effective screening, prevention, treatment, and control of both acute and chronic conditions.

Studies must include validated behavioral, clinical, or other biomedical health outcomes and actionable endpoints with real-world implications. Investigators should clearly define the health condition(s), projected health outcomes and their public health or clinical meaning, and justify the focus in the selected population(s). In alignment with NIH/HHS priorities, studies will adhere to the tenets of rigor, reproducibility, and generalizability to strengthen gold-standard science.

  • Research Scientist Development Award (K01)
  • Clinical Investigator Award (K08)
  • Mentored Patient-Oriented Research Career Development Award (K23)
  • Midcareer Investigator Award in Patient-Oriented Research (K24)
  • Career Transition Award (K99)
  • Research Transition Award (R00)
Individual Career Development Salary Fringe Benefits:

K01 & K99:
Salary Support: Up to $75,000 plus fringe benefits per year.
Research Support: Up to $25,000 per year.

K08 & K23:
Salary Support: Up to $100,000 plus fringe benefits per year.
Research Support: Up to $25,000 per year.

K24:
Salary Support: Up to the maximum legislative salary cap plus fringe benefits per year, for 25% effort.  Applications requesting more than 3.0 calendar months of PI salary support will not be reviewed.
Research Support: Up to $50,000 per year.

Individual Career Development Contacts:

Scientific Program Contact:
E-mail: [email protected] 

Grants Management Contact:
Email: [email protected]

Individual Fellowship
In addition to our Individual Fellowships Overview, consider the following NIMHD-specific information.
Individual Fellowships Interest Areas:

The National Institute on Minority Health and Health Disparities (NIMHD) is committed to the development of the next generation of biomedical scientists relevant to its mission by supporting the following Ruth L. Kirschstein National Research Service Award (NRSA) Fellowships: 

  • Individual Predoctoral NRSA for MD/Ph.D. Fellowships (F30) 
  • Predoctoral Individual National Research Service Award (F31) 
  • Postdoctoral Individual National Research Service Award (F32) 
Individual Fellowships Project Period Considerations:
NIMHD may limit project periods for specific education activities, as follows:

Individuals may receive up to 5 years of aggregate Kirschstein-NRSA support at the predoctoral level (up to 6 years for dual degree training, e.g., MD/PhD), and up to 3 years of aggregate Kirschstein-NRSA support at the postdoctoral level, including any combination of support from institutional training grants (e.g., T32) and an individual fellowship award. 

Individual Fellowships Budget Considerations:
Individual Fellowships Contacts:

All prospective fellowship applicants are strongly encouraged to contact the NIMHD Training Team before preparing an application to determine the relevance of their proposed research to NIMHD.  

Scientific Program Contact:
E-mail: [email protected]

Grants Management Contact:
Email: [email protected]

 

Institutional Career Development
In addition to our Institutional Career Development, consider the following NIMHD-specific information.
Institutional Career Development Interest Areas:

NIMHD does not currently fund Institutional Career Development Awards.

Institutional Training
In addition to our Institutional Training, consider the following NIMHD-specific information.
Institutional Training Interest Areas:

NIMHD does not currently participate in Institutional Training Award programs.

Research Education
In addition to our Research Education overview, consider the following NIMHD-specific information.
Research Education Funding Instruments:
NIMHD does not award Research Education Cooperative Agreements (UE5)
NIMHD awards Research Education Grant Projects (R25)
Research Education Contacts:

All prospective research education applicants are strongly encouraged to contact the NIMHD Training Team before preparing an application to determine the relevance of their proposed research to NIMHD.  

Scientific Program Contact:
E-mail: [email protected]

Grants Management Contact:
Email: [email protected]

 

Research Projects
Interest Areas:

NIMHD is interested in research project applications in any of our general interest areas. Funding priority may be given to applications on one of our highlighted topics and applications submitted in response to topic specific funding opportunities. 

Contacts:

Scientific Program Contact: 

Division of Clinical and Health Services Research 
[email protected] 

Division of Community Health and Population Science 
[email protected] 

Division of Integrative Biological and Behavioral Sciences 
[email protected] 

Grants Management Contact: 
[email protected] 

Scope Note:
In addition to our Research Projects, overview, consider the following NIMHD-specific information.
Small Business
In addition to our Small Business overview, consider the following NIMHD-specific information.
Small Business Interest Areas:

The National Institute on Minority Health and Health Disparities (NIMHD) is interested in supporting the development of technologies, products, or services for commercialization with the aim of improving health in populations that experience health disparities. Appropriate technologies should be effective, affordable, and acceptable. Specific scientific areas of interest include, but are not limited to, the following topics: 

  • Health Care Access and Quality - Solutions that improve access to and/or promote enhanced quality of health care. 
  • Care Coordination and Patient Engagement - Solutions that improve care coordination, self-management, and patient-provider communication. 
  • Health Promotion/Disease Prevention - Interventions that empower individuals, families, and communities to engage in health-promoting behaviors and improve health outcomes. 
  • Women’s Health Across the Lifespan - Solutions that improve prevention, diagnosis, and care for women from adolescence through aging.  
  • Digital Health - Solutions including telehealth and mobile health (mHealth) that improve communication, care delivery, and engagement among providers, patients, and families. 
  • Environmental Health - Tools and methods to detect, measure, and analyze environmental exposures contributing to health outcomes. 
  • Disaster Health and Resilience - Interventions that reduce adverse health outcomes and promote resilience and recovery in populations affected by natural disasters or public health emergencies. 
  • Data Science - Technologies that leverage big data, AI, electronic health records, and advanced analytics to understand and improve care. 
  • Rehabilitation and Assistive Technologies - Innovations in physical medicine and rehabilitation, particularly those tailored for aging populations and individuals with disabilities. 
  • Clinical Trials Innovation - Technologies that expand access to clinical trials and research (e.g., decentralized trials, remote monitoring) to improve recruitment and retention. 
Approved Topics for Awards Over Statutory Budget Guidelines:
  • Products, technologies, or services designed to improve access to and utilization of existing and emerging technologies that enhance healthcare delivery, including improving mobility and accessibility for people with disabilities; promoting healthy lifestyles; increasing knowledge, prevention, and management of chronic diseases; strengthening patient–clinician communication; and enhancing surveillance to reduce the spread and impact of communicable and non-communicable diseases.  
  • Telehealth, telemedicine, remote patient monitoring, and mobile health technologies designed to improve access to specialty care, primary care, and clinical research. Examples include solutions that support timely diagnosis, early intervention, treatment adherence, and remote clinical management for both adult and pediatric populations.
  • Products, technologies, or services that leverage existing or emerging data-driven technologies—such as electronic health record systems, biomedical informatics platforms, big data resources and analytics, precision medicine, precision health, precision nutrition, and predictive analytics—to improve the dissemination and use of medical and health information. These solutions should use data to increase health knowledge, reduce educational barriers, and promote greater utilization of health services.
  • Products, technologies, or services—including, but not limited to, the development of novel analytical tools, methods, and interventions—for the early detection of disease, pre-disease states, or adverse health conditions arising from traditional risk factors as well as social and structural determinants known to compromise health. These technologies may include novel or validated biomarkers identified in saliva, breath, blood, microbiota, or other biological tissues and specimens.  
  • Innovative products, services, or technologies that enable real-time or cumulative monitoring of physiological, physical, social, and environmental exposures across the life course are encouraged. These tools can enhance understanding of how biological, social, and structural factors influence health and health access, and empower individuals and communities to identify and mitigate harmful exposures. Examples include precision medicine and nutrition tools, wearable technologies, -omics platforms, predictive analytics, robotics, virtual and augmented reality, geographic information systems (GIS) and spatial analysis, and e-mental health interventions that support psychosocial well-being.
  • Technologies that prevent or reduce harmful exposures, support the collection and analysis of data on social and environmental health risks (e.g., violence, post-traumatic stress disorder), and promote health, resilience, and recovery in the context of disasters are encouraged. Disasters include events declared under the Stafford Act, HHS public health emergencies, or other local, regional, or national incidents. These may be natural (e.g., hurricanes, floods, wildfires, earthquakes), human-made (e.g., chemical spills, nuclear contamination), or infectious disease outbreaks (e.g., influenza, Zika, dengue). Disasters may also result in long-term impacts—defined as lasting one year or more—on infrastructure, economic stability, housing, and public health systems.
  • Technologies designed to improve and train researchers and clinicians the effectiveness of recruiting, enrolling, and retaining participants in clinical trials, interventions, and other research studies involving human subjects within varying contexts (e.g. rural, urban), and appropriate health services delivery at the community level.
  • Products and services that clearly align with and support the effectiveness and improvement federal programs and service providers—including HRSA, SAMHSA, CMS, ACF, and ACL—such as Federally Qualified Health Centers (FQHCs), critical access hospitals, and other rural providers, as well as NIH research initiatives like All of Us, IMPROVE, CEAL, and   other NIH funded research centers.
  • Supporting entrepreneurial research and the development of innovative products and interventions that reduce barriers to access and quality in women’s health and research—including challenges related to access to care, research participation, data science, and workforce capacity. These efforts focus on services, prevention strategies, medical devices, and digital health solutions that improve the quality of and access to care for women experiencing health disparities across the life course, including pre-pregnancy, in utero, childhood/adolescence, adulthood, and older age.
Phase IIB & Commercialization Readiness Pilot (CRP):
NIMHD accepts Phase IIB SBIR projects
NIMHD accepts Commercialization Readiness Pilot (CRP) projects
Clinical Trials:
NIMHD accepts clinical trials through the SBIR programs
NIMHD accepts clinical trials through the STTR programs
NIMHD accepts clinical trials through the Phase IIB SBIR program
NIMHD accepts clinical trials through the Commercialization Readiness Pilot (CRP)
Small Business Contact:

Scientific Program Contact:
NIMHD Small Business Program 
NIMHDSBIR/STTR 

Grants Management Contact:
Email: [email protected]


For technical issues E-mail OER Webmaster